Literature DB >> 26467754

Sensory neuronopathies.

Kelly Graham Gwathmey1.   

Abstract

The sensory neuronopathies (or ganglionopathies) are a small subcategory of neuropathies characterized by primary degeneration of the dorsal root ganglia and trigeminal ganglion sensory neurons, resulting in a distinctive clinical presentation. Patients typically have subacute onset of asymmetric, non-length-dependent sensory impairment and early ataxia. The etiologies of acquired sensory neuronopathies are rather limited. Early identification is imperative, as they may herald an underlying malignancy or an autoimmune condition such as Sjögren syndrome. This review addresses the various causes of acquired sensory neuronopathies, the recommended diagnostic approach, and treatment options. Finally, I will briefly discuss a select few hereditary and degenerative sensory neuronopathies, which, in contrast to the acquired disorders, are slowly progressive and are usually associated with additional neurological symptoms.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sjögren syndrome; dorsal root ganglion; paraneoplastic neuropathy; sensory ganglionopathy; sensory neuronopathy

Mesh:

Year:  2015        PMID: 26467754     DOI: 10.1002/mus.24943

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

2.  Sweat Gland Denervation in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS).

Authors:  Chizoba C Umeh; Michael Polydefkis; Vinay Chaudhry; David S Zee
Journal:  Mov Disord Clin Pract       Date:  2016-04-05

3.  Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic.

Authors:  Andrea Cortese; Ilaria Callegari; Riccardo Currò; Elisa Vegezzi; Silvia Colnaghi; Maurizio Versino; Enrico Alfonsi; Giuseppe Cosentino; Enzamaria Valente; Simone Gana; Cristina Tassorelli; Anna Pichiecchio; Alexander M Rossor; Enrico Bugiardini; Antonio Biroli; Daniela Di Capua; Henry Houlden; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-09-17       Impact factor: 10.154

Review 4.  The ataxic neuropathies.

Authors:  Stéphane Mathis; Fanny Duval; Antoine Soulages; Guilhem Solé; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849

5.  Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma.

Authors:  Panagiotis Zis; Dasappaiah Ganesh Rao; Bart E Wagner; Lucinda Nicholson-Goult; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2017-01-05

Review 6.  Peripheral Nervous System Involvement in Lymphoproliferative Disorders.

Authors:  Mario Sabatelli; Luca Laurenti; Marco Luigetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-09-01       Impact factor: 2.576

7.  Advanced Technology for Gene Delivery with Homing Peptides to Spinal Cord through Systemic Circulation in Mice.

Authors:  Tomoya Terashima; Nobuhiro Ogawa; Toshiyuki Sato; Miwako Katagi; Yuki Nakae; Junko Okano; Hiroshi Maegawa; Hideto Kojima
Journal:  Mol Ther Methods Clin Dev       Date:  2019-05-10       Impact factor: 6.698

8.  Diagnosis of peripheral neuropathy.

Authors:  Helmar C Lehmann; Gilbert Wunderlich; Gereon R Fink; Claudia Sommer
Journal:  Neurol Res Pract       Date:  2020-07-15

9.  Magnetic resonance imaging of the spinal cord in the evaluation of 3 patients with sensory neuronopathies: Diagnostic assessment, indications of treatment response, and impact of autoimmunity: A case report.

Authors:  Julius Birnbaum; Aliya Lalji; Ezequiel A Piccione; Izlem Izbudak
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 10.  Paraneoplastic Diseases of the Central Nervous System.

Authors:  Jonathan Galli; John Greenlee
Journal:  F1000Res       Date:  2020-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.